Since we have established a novel oncogenic cross-talk between Raf/MAPK signaling and Aurora-A kinase in the activation of EMT and breast cancer progression [26], we aimed to determine the role of Aurora-A in promoting Raf/MAPK-induced chemoresistance. This evidence concerns the gene RAF1 and breast carcinoma.